BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27566653)

  • 1. Phospho-Network Analysis Identifies and Quantifies Hepatitis C Virus (HCV)-induced Hepatocellular Carcinoma (HCC) Proteins Regulating Viral-mediated Tumor Growth.
    Lu NT; Liu NM; Vu JQ; Patel D; Cohn W; Capri J; Ziegler M; Patel N; Tramontano A; Williams R; Whitelegge J; French SW
    Cancer Genomics Proteomics; 2016 09-10; 13(5):339-57. PubMed ID: 27566653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.
    Han Y; Niu J; Wang D; Li Y
    PLoS One; 2016; 11(4):e0153882. PubMed ID: 27115606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines.
    Ye F; Xin Z; Han W; Fan J; Yin B; Wu S; Yang W; Yuan J; Qiang B; Sun W; Peng X
    PLoS One; 2015; 10(11):e0142082. PubMed ID: 26544179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
    Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
    J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
    Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
    Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.
    Schwegler EE; Cazares L; Steel LF; Adam BL; Johnson DA; Semmes OJ; Block TM; Marrero JA; Drake RR
    Hepatology; 2005 Mar; 41(3):634-42. PubMed ID: 15726646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Hepatitis C Virus in the dynamic protein interaction networks of hepatocellular cirrhosis and carcinoma.
    Huang T; Liu L; Liu Q; Ding G; Tan Y; Tu Z; Li Y; Dai H; Xie L
    Int J Comput Biol Drug Des; 2011; 4(1):5-18. PubMed ID: 21330691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DKK1 in relation to HCV induced liver cirrhosis and HCV induced HCC curative resection.
    Essa ES; Montaser BA; Badawy MT; Essa AS; Mokhtar MS
    Acta Gastroenterol Belg; 2016; 79(3):309-313. PubMed ID: 27821026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
    Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
    World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma.
    Lin YT; Chien KY; Wu CC; Chang WY; Chu LJ; Chen MC; Yeh CT; Yu JS
    J Proteomics; 2017 Mar; 157():40-51. PubMed ID: 28192239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
    Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the tumor necrosis factor (TNF)--Fas L and HCV in the development of hepatocellular carcinoma.
    Nada O; Abdel-Hamid M; Ismail A; El Shabrawy L; Sidhom KF; El Badawy NM; Ghazal FA; El Daly M; El Kafrawy S; Esmat G; Loffredo CA
    J Clin Virol; 2005 Oct; 34(2):140-6. PubMed ID: 16157266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.
    Zheng Z; Sze CW; Keng CT; Al-Haddawi M; Liu M; Tan SY; Kwek HL; Her Z; Chan XY; Barnwal B; Loh E; Chang KTE; Tan TC; Tan YJ; Chen Q
    PLoS One; 2017; 12(9):e0184127. PubMed ID: 28886065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
    Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
    J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
    Amin MA; Awadein MR; Gabr H
    Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of hepatocellular carcinoma development by plasma ADAMTS13 in chronic hepatitis B and C.
    Ikeda H; Tateishi R; Enooku K; Yoshida H; Nakagawa H; Masuzaki R; Kondo Y; Goto T; Shiina S; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Ono T; Koike K; Yatomi Y
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2204-11. PubMed ID: 21876190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.
    Liu CC; Wang YH; Chuang EY; Tsai MH; Chuang YH; Lin CL; Liu CJ; Hsiao BY; Lin SM; Liu LY; Yu MW
    Mol Carcinog; 2014 Jan; 53(1):58-66. PubMed ID: 22911910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristic mutations in hepatitis C virus core gene related to the occurrence of hepatocellular carcinoma.
    Hu Z; Muroyama R; Kowatari N; Chang J; Omata M; Kato N
    Cancer Sci; 2009 Dec; 100(12):2465-8. PubMed ID: 20175782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.